Literature DB >> 16527133

[Review of the interference between the most commonly prescribed drugs and clinical analyses at the Primary Health Care Centre of L'Hospitalet de Llobregat].

R Vargas1, N Torné, P Travé, M March, G Rodríguez, S Calero.   

Abstract

OBJECTIVE: To analyse the concordance of published information on probable drug interactions and the results of clinical analyses.
DESIGN: Bibliographical review of the 50 most commonly prescribed drug products at the Primary Health Centre of L'Hospitalet de Llobregat, Barcelona, Spain, in 2002 and 2003. DATA SOURCE: Six bibliographical sources consisting of drug product catalogues and reference books. MEASUREMENTS: Interference with the 56 drug products studied.
RESULTS: Most theoretical interference belonged to the therapeutic group of anti-inflammatory drugs. The drug products with most interference were hydrochlorothiazide (diuretic) and gliclazide (lipid lowering). The most frequent interference was in the increase of transaminases, thrombocytopaenia, leukopaenia, hyperglycaemia, and hyperuricaemia. Only in 12% of the points of interference analysed was the rate of concordance among the various bibliographical sources reviewed higher than 50%. The highest rate of concordance was found in the diuretics.
CONCLUSIONS: Consultation of a single bibliographical source does not necessarily ensure the obtaining of reliable data on possible drug interference. This study demonstrates the need to standardize information on drug interference and to include the medication that the patient follows on the analysis application form.

Entities:  

Mesh:

Year:  2006        PMID: 16527133      PMCID: PMC7668732          DOI: 10.1157/13085340

Source DB:  PubMed          Journal:  Aten Primaria        ISSN: 0212-6567            Impact factor:   1.137


  7 in total

1.  Drug interference in clinical chemistry: recommendation of drugs and their concentrations to be used in drug interference studies.

Authors:  O Sonntag; A Scholer
Journal:  Ann Clin Biochem       Date:  2001-07       Impact factor: 2.057

Review 2.  [Great number of non-recorded cases of analytical interference. Unexpected and misinterpreted laboratory levels can result in diagnostic and therapeutic errors].

Authors:  Göran Lindstedt; Rolf Ekman; Rosanne Forberg; Anders Isaksson; Mats Stridsberg; Lena Hård; Gunnar Nordin; Ernst Nyström
Journal:  Lakartidningen       Date:  2002-05-30

Review 3.  Interference with clinical laboratory analyses.

Authors:  M H Kroll; R J Elin
Journal:  Clin Chem       Date:  1994-11       Impact factor: 8.327

Review 4.  Drug interferences with clinical laboratory tests.

Authors:  P P Sher
Journal:  Drugs       Date:  1982-07       Impact factor: 9.546

5.  Effect of drugs on laboratory tests. Guidelines for evaluation of analytical interference (document B, stage 3, version 1).

Authors:  M M Galteau; G Siest
Journal:  Ann Biol Clin (Paris)       Date:  1984       Impact factor: 0.459

6.  Drug interference with laboratory value interpretation: A review.

Authors:  J L Hansen; F N Schneiweiss
Journal:  Am J Med Technol       Date:  1981-03

Review 7.  Review of abnormal laboratory test results and toxic effects due to use of herbal medicines.

Authors:  Amitava Dasgupta
Journal:  Am J Clin Pathol       Date:  2003-07       Impact factor: 2.493

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.